Naltrexone Hydrochloride Tablet — FDA Drug Shortage

No longer listed by FDA — Chartwell Molecular Holdings LLC

The FDA lists a drug shortage record for Naltrexone Hydrochloride Tablet (tablet) from Chartwell Molecular Holdings LLC with status No longer listed by FDA. The shortage was first posted on Feb 29, 2024.

Shortage details

Status
No longer listed by FDA
Company
Chartwell Molecular Holdings LLC
Package NDC
62135-242-60
Dosage Form
Tablet
Presentation
Naltrexone Hydrochloride, Tablet, 50 mg (NDC 62135-242-60)
Initial Posting
Feb 29, 2024

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.